HealthEquity (NASDAQ:HQY) Updates FY 2026 Earnings Guidance

by · The Cerbat Gem

HealthEquity (NASDAQ:HQY – Get Free Report) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 3.870-3.950 for the period, compared to the consensus estimate of 3.620. The company issued revenue guidance of $1.3 billion-$1.3 billion, compared to the consensus revenue estimate of $1.3 billion.

HealthEquity Trading Down 0.2%

NASDAQ:HQY traded down $0.24 on Wednesday, reaching $98.64. 1,542,275 shares of the stock traded hands, compared to its average volume of 995,596. HealthEquity has a 1-year low of $74.07 and a 1-year high of $116.65. The company has a current ratio of 4.23, a quick ratio of 4.23 and a debt-to-equity ratio of 0.47. The company’s 50 day moving average is $96.34 and its 200-day moving average is $96.87. The firm has a market capitalization of $8.50 billion, a price-to-earnings ratio of 59.78, a price-to-earnings-growth ratio of 1.47 and a beta of 0.18.

HealthEquity (NASDAQ:HQY – Get Free Report) last released its quarterly earnings data on Tuesday, September 2nd. The company reported $0.92 earnings per share for the quarter, hitting the consensus estimate of $0.92. The firm had revenue of $325.80 million for the quarter, compared to the consensus estimate of $320.68 million. HealthEquity had a net margin of 11.49% and a return on equity of 12.04%. Equities research analysts anticipate that HealthEquity will post 2.32 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

HQY has been the subject of several analyst reports. Barrington Research reiterated an “outperform” rating and issued a $125.00 price objective on shares of HealthEquity in a research report on Friday, August 29th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of HealthEquity in a report on Wednesday, October 8th. KeyCorp decreased their price target on shares of HealthEquity from $125.00 to $120.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 8th. Wall Street Zen cut shares of HealthEquity from a “buy” rating to a “hold” rating in a research report on Saturday, November 15th. Finally, Royal Bank Of Canada increased their target price on shares of HealthEquity from $109.00 to $110.00 and gave the company an “outperform” rating in a research note on Wednesday, September 3rd. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, HealthEquity presently has a consensus rating of “Moderate Buy” and an average target price of $119.00.

Check Out Our Latest Report on HealthEquity

Insider Buying and Selling at HealthEquity

In other news, EVP Michael Henry Fiore sold 1,781 shares of HealthEquity stock in a transaction dated Tuesday, October 7th. The stock was sold at an average price of $88.21, for a total value of $157,102.01. Following the completion of the transaction, the executive vice president owned 49,795 shares in the company, valued at approximately $4,392,416.95. This trade represents a 3.45% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Delano Ladd sold 1,500 shares of the business’s stock in a transaction on Thursday, November 20th. The shares were sold at an average price of $104.56, for a total transaction of $156,840.00. Following the completion of the sale, the executive vice president directly owned 75,479 shares of the company’s stock, valued at approximately $7,892,084.24. This trade represents a 1.95% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 10,781 shares of company stock valued at $1,016,707. 1.50% of the stock is owned by insiders.

Institutional Trading of HealthEquity

Several hedge funds have recently bought and sold shares of HQY. Larson Financial Group LLC increased its holdings in HealthEquity by 24.4% in the 3rd quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock valued at $60,000 after buying an additional 123 shares during the period. iSAM Funds UK Ltd bought a new stake in shares of HealthEquity in the third quarter worth about $117,000. Meiji Yasuda Asset Management Co Ltd. acquired a new position in HealthEquity during the 2nd quarter worth approximately $217,000. Merit Financial Group LLC boosted its stake in shares of HealthEquity by 8.9% during the 3rd quarter. Merit Financial Group LLC now owns 2,112 shares of the company’s stock worth $200,000 after acquiring an additional 172 shares during the period. Finally, Advisory Services Network LLC bought a new position in shares of HealthEquity during the third quarter worth approximately $207,000. 99.55% of the stock is currently owned by institutional investors.

About HealthEquity

(Get Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Further Reading